Société BIC SA (BICEY)
OTCMKTS · Delayed Price · Currency is USD
30.57
+0.18 (0.58%)
Aug 7, 2025, 12:27 PM EDT
Verve Therapeutics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 177.01 | 212.01 | 226.52 | 198.6 | 314.2 | 93.72 | Upgrade |
Depreciation & Amortization | 105.39 | 107.39 | 111.5 | 111.26 | 106.7 | 110.17 | Upgrade |
Other Amortization | 7.9 | 7.9 | 8.89 | 5.95 | 5.1 | 4.98 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | - | -170.6 | -0.13 | Upgrade |
Asset Writedown & Restructuring Costs | 25.14 | 25.14 | 0.97 | 2.14 | 0 | 44.06 | Upgrade |
Stock-Based Compensation | 9.84 | 9.84 | 14.39 | 14.66 | 10.45 | 5.44 | Upgrade |
Other Operating Activities | -14.28 | -22.28 | 18.42 | -3.42 | 34.65 | -30.36 | Upgrade |
Change in Accounts Receivable | -28.51 | -28.51 | - | - | - | - | Upgrade |
Change in Inventory | 32.01 | 32.01 | - | - | - | - | Upgrade |
Change in Accounts Payable | 11.47 | 11.47 | - | - | - | - | Upgrade |
Change in Other Net Operating Assets | -17.25 | 2.75 | -27.38 | -29.2 | -19.93 | 129.75 | Upgrade |
Operating Cash Flow | 308.71 | 357.71 | 353.3 | 299.99 | 280.56 | 357.65 | Upgrade |
Operating Cash Flow Growth | -18.00% | 1.25% | 17.77% | 6.93% | -21.55% | 12.73% | Upgrade |
Capital Expenditures | -82.54 | -80.54 | -94.33 | -83.59 | -66.18 | -76.73 | Upgrade |
Cash Acquisitions | -201.27 | -201.27 | - | -73.79 | -7.15 | -72.54 | Upgrade |
Divestitures | - | - | - | 1.1 | 132.54 | - | Upgrade |
Sale (Purchase) of Intangibles | -6.37 | -6.37 | -10.27 | -12.68 | -8.69 | -6.37 | Upgrade |
Investment in Securities | 4.69 | 4.69 | -10.96 | -6.41 | 0.41 | 3.65 | Upgrade |
Other Investing Activities | -3.21 | -0.21 | 1.5 | 2.91 | 6.64 | 2.73 | Upgrade |
Investing Cash Flow | -288.71 | -283.71 | -114.06 | -172.46 | 57.57 | -149.26 | Upgrade |
Long-Term Debt Issued | - | 151.86 | 7.5 | - | - | 77.24 | Upgrade |
Long-Term Debt Repaid | - | -20.51 | -18.02 | -27.76 | -28.64 | -18.87 | Upgrade |
Net Debt Issued (Repaid) | 123.34 | 131.34 | -10.53 | -27.76 | -28.64 | 58.37 | Upgrade |
Repurchase of Common Stock | -38.98 | -54.98 | -115.88 | -53.83 | -38.85 | -7.53 | Upgrade |
Common Dividends Paid | -185.95 | -177.95 | -110.22 | -94.74 | -80.92 | -110.21 | Upgrade |
Other Financing Activities | 24.33 | 28.33 | 44.56 | 1.16 | 0.14 | -1.73 | Upgrade |
Financing Cash Flow | -77.26 | -73.26 | -192.06 | -175.18 | -148.27 | -61.11 | Upgrade |
Foreign Exchange Rate Adjustments | -17.43 | -12.43 | 5.31 | -5.55 | 13.82 | -29.39 | Upgrade |
Net Cash Flow | -74.68 | -11.68 | 52.5 | -53.19 | 203.68 | 117.89 | Upgrade |
Free Cash Flow | 226.17 | 277.17 | 258.97 | 216.4 | 214.38 | 280.92 | Upgrade |
Free Cash Flow Growth | -21.99% | 7.03% | 19.67% | 0.95% | -23.69% | 29.04% | Upgrade |
Free Cash Flow Margin | 10.60% | 12.62% | 11.44% | 9.69% | 11.70% | 17.26% | Upgrade |
Free Cash Flow Per Share | 5.41 | 6.58 | 5.99 | 4.86 | 4.77 | 6.23 | Upgrade |
Cash Interest Paid | 12.1 | 12.1 | 10.65 | - | - | - | Upgrade |
Cash Income Tax Paid | 122.76 | 122.76 | 80.77 | 81.78 | 100.42 | 50.03 | Upgrade |
Levered Free Cash Flow | 141.31 | 225.42 | 235.37 | 136.73 | 217.7 | 324.14 | Upgrade |
Unlevered Free Cash Flow | 155.96 | 233.2 | 242.03 | 142.1 | 220.03 | 326.99 | Upgrade |
Change in Net Working Capital | 50.52 | -2.09 | -12.16 | 80.8 | -0.23 | -150.49 | Upgrade |
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.